Saturday, October 31, 2026

FIRST REPUBLIC BANK Stock Went Down By Over 31% At Session Start Today

FIRST REPUBLIC BANK Stock Went Down By Over 31% At Session Start Today

(VIANEWS) - Shares of FIRST REPUBLIC BANK (NYSE: FRC) fell by a staggering 31.19% to $66.06 at 10:17 EST on Friday, after five consecutive sessions in a row of losses. NYSE is falling 0.58% to $15,053.32, following the last session's downward trend. This seems, at the moment, a somewhat down trend trading session today.

FIRST REPUBLIC BANK's last close was $96.01, 44.99% below its 52-week high of $174.54.

About FIRST REPUBLIC BANK

First Republic Bank, together with its subsidiaries, provides private banking, private business banking, and private wealth management services to clients in metropolitan areas in the United States. It operates in two segments, Commercial Banking and Wealth Management. The company accepts deposit products, such as noninterest-bearing checking, interest-bearing checking, money market checking accounts, money market savings accounts, and passbook accounts, as well as certificates of deposit. It also offers a range of lending products that comprise residential mortgage loans, home equity lines of credit, multifamily loans, commercial real estate and construction loans, personal and business loans, single family construction loans, and other loans and lines of credit to businesses and individuals. The company's loans are secured by single family residences, multifamily buildings, and commercial real estate properties. In addition, it provides wealth management services, which include various investment strategies and products, online investment management, trust and custody, full service and online brokerage, financial and estate planning, and access to alternative investments, as well as investing, insurance, and foreign exchange services. Further, the company offers online and mobile banking services; refinancing services; and ATM and debit cards. As of December 31, 2021, it offered its services through 82 licensed deposit taking offices primarily in the San Francisco, Palo Alto, Los Angeles, Santa Barbara, Newport Beach and San Diego, California; Portland, Oregon; Boston, Massachusetts; Palm Beach, Florida; Greenwich, Connecticut; New York, New York; and Jackson, Wyoming. It also has 12 additional offices that offer lending, wealth management, or trust services. First Republic Bank was founded in 1985 and is headquartered in San Francisco, California.

Earnings Per Share

As for profitability, FIRST REPUBLIC BANK has a trailing twelve months EPS of $6.4.

PE Ratio

FIRST REPUBLIC BANK has a trailing twelve months price to earnings ratio of 10.32. Meaning, the purchaser of the share is investing $10.32 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.99%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is a negative 29.5% and a negative 34.7%, respectively.

Yearly Top and Bottom Value

FIRST REPUBLIC BANK's stock is valued at $66.06 at 10:17 EST, way under its 52-week low of $106.86.

Volatility

FIRST REPUBLIC BANK's last week, last month's, and last quarter's current intraday variation average was a negative 1.21%, a negative 1.13%, and a positive 1.63%.

FIRST REPUBLIC BANK's highest amplitude of average volatility was 3.15% (last week), 1.73% (last month), and 1.63% (last quarter).

More news about FIRST REPUBLIC BANK (FRC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com